Literature DB >> 15886203

Cross-talk between signaling pathways regulates alternative splicing: a novel role for JNK.

Federico Pelisch1, Matías Blaustein, Alberto R Kornblihtt, Anabella Srebrow.   

Abstract

The regulation of alternative splicing by extracellular signals represents a key event in the control of gene expression. There is increasing evidence showing that many extracellular cues regulate alternative splicing. Nevertheless, the broad picture regarding the role of different signaling pathways and their interaction remains incomplete. Using the fibronectin gene as a model, we show that a laminin-rich basement membrane regulates the alternative splicing of two out of three regions of the transcript (extra domain I and type III connecting segment) in mammary epithelial cells, through a non-stress c-Jun N-terminal kinase (JNK) signaling pathway. We propose that dephosphorylation of the extracellular signal-regulated kinase is involved in this regulatory process. Furthermore, the laminin-rich basement membrane blocks the effect of a mammary mesenchymal cell-conditioned medium, which stimulates the inclusion of extra domain I and type III connecting segment through a phosphatidylinositol3-kinase-dependent cascade, indicating that JNK signaling can inhibit the phosphatidylinositol 3-kinase-mediated splicing regulation. These results implicate JNK in the regulation of alternative splicing and provide new evidence on how extracellular stimuli are converted into changes in splicing patterns, strengthening the view that the control of alternative splicing is as complex and relevant as transcriptional control, together accounting for the spatiotemporal requirements of gene expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886203     DOI: 10.1074/jbc.M412007200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Combinatorial control of signal-induced exon repression by hnRNP L and PSF.

Authors:  Alexis A Melton; Jason Jackson; Jiarong Wang; Kristen W Lynch
Journal:  Mol Cell Biol       Date:  2007-07-30       Impact factor: 4.272

Review 2.  Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences.

Authors:  Carmen Berasain; Saioa Goñi; Josefa Castillo; María Ujue Latasa; Jesús Prieto; Matías A Avila
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

3.  Characterization of zebrafish Esrom (Myc-binding protein 2) RCC1-like domain splice variants.

Authors:  Hui Wang
Journal:  Mol Cell Biochem       Date:  2010-02-09       Impact factor: 3.396

4.  Mitogen-activated protein kinase phosphorylation of splicing factor 45 (SPF45) regulates SPF45 alternative splicing site utilization, proliferation, and cell adhesion.

Authors:  Adnan M Al-Ayoubi; Hui Zheng; Yuying Liu; Tao Bai; Scott T Eblen
Journal:  Mol Cell Biol       Date:  2012-05-21       Impact factor: 4.272

Review 5.  More than a messenger: Alternative splicing as a therapeutic target.

Authors:  A J Black; J R Gamarra; J Giudice
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-02       Impact factor: 4.490

Review 6.  Minor fibrillar collagens, variable regions alternative splicing, intrinsic disorder, and tyrosine sulfation.

Authors:  Ming Fang; Reed Jacob; Owen McDougal; Julia Thom Oxford
Journal:  Protein Cell       Date:  2012-07-01       Impact factor: 14.870

7.  Regulation of transcription of the RNA splicing factor hSlu7 by Elk-1 and Sp1 affects alternative splicing.

Authors:  Moti Alberstein; Maayan Amit; Keren Vaknin; Amanda O'Donnell; Chen Farhy; Yaniv Lerenthal; Noam Shomron; Ohad Shaham; Andrew D Sharrocks; Ruth Ashery-Padan; Gil Ast
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

8.  Protein kinase C-dependent control of Bcl-x alternative splicing.

Authors:  Timothée Revil; Johanne Toutant; Lulzim Shkreta; Daniel Garneau; Philippe Cloutier; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

9.  Alternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B cells.

Authors:  Xiaosheng Wu; Jaime R Darce; Sook Kyung Chang; Grzegorz S Nowakowski; Diane F Jelinek
Journal:  Blood       Date:  2008-08-06       Impact factor: 22.113

10.  EVI1 splice variants modulate functional responses in ovarian cancer cells.

Authors:  Punashi Dutta; Tuyen Bui; Kyle A Bauckman; Khandan Keyomarsi; Gordon B Mills; Meera Nanjundan
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.